Inbrain Neuroelectronics invents neuroelectronic therapies to address neural disorders. The company utilizes graphene technology to develop high-resolution brain-computer interfaces and implantable neuroprocessors, focusing on enhancing patient outcomes through personalized therapy.

Inbrain Neuroelectronics

INBRAIN Neuroelectronics | 16,531 followers on LinkedIn. High density and high resolution graphene intelligent neural systems for BCI therapeutics *FDA Breakthrough Designation* | High density and high resolution graphene intelligent neural systems for central and peripheral Neuroelectronic applications. *FDA breakthrough Designation* Pioneering Precision Neurology

Professor of Business Administration (Marketing) - IESE Business School

Mario Capizzani

Medical Device Development specialist

Marini Witjes

Head of embedded engineering

Martijn Hazenberg

Senior Embedded Engineer en INBRAIN Neuroelectronics

Daniel Martin

INBRAIN Neuroelectronics

Thanks Nasdaq for celebrating our $50M Series B financing led by imec.xpand . 🔥🔥🔥 New investors EIC Fund, Fond ICO Next Tech, CDTI-Innvierte and AVANÇSA , and existing investors Asabys Partners , Aliath Bioventures and Vsquared Ventures also participated, bringing the total amount raised since inception to $68 million. The company’s technology utilizes the unique properties of #graphene , a Nobel Prize-winning material known for its strength, flexibility, and conductivity. Read our press release: https://lnkd.in/eBvGGr93 Watch CEO Carolina Aguilar on Bloomberg Television : https://lnkd.in/e9MJjaNh

Graphene implants decode the complexities of the human brain INBRAIN Neuroelectronics CEO Carolina Aguilar explains how new advances in BCI technology have the potential to diagnose and treat multiple brain conditions in real-time. #longevity #neurotech #graphene #BCI #brain

Longevity.Technology

Thanks Longevity.Technology for speaking with our CEO Carolina Aguilar about our recent updates! 🧠🧠 Using Parkinson’s disease as an example, Aguilar says that understanding how and where certain effects are triggered is key. By identifying the specific neural patterns and activity associated with different brain functions and dysfunctions, Inbrain’s technology can precisely decode the origins of symptoms. This allows the company to deliver targeted therapeutic interventions to treat the underlying neural issues. Read the article by Danny Sullivan : https://lnkd.in/e9amHBdG

Last Tuesday, INBRAIN Neuroelectronics had the opportunity to participate in the Neurotechnology's rapid evolution – What consequences for the EU regulatory landscape? hybrid event organised by The International Center for Future Generations - ICFG and hosted by @Euractiv. Javier Castillo , our Head of Quality and Regulatory participated in the discussion together with Antonia Mochan , Guilherme Maia de Oliveira Wood, Ricardo Chavarriaga , Arleen Salles , PhD, and Virginia Mahieu ! A great opportunity to understand the Neurotechnology governance and strategy in the EU as well as the rapidly evolving landscape globally.

Join us at Impact/Week for an exciting conversation on Revolutionizing Healthcare through Advanced Materials Our Managing Partner, Josep Ll. Sanfeliu , will be on stage with Jose Antonio Garrido , Vice Director at the Institut Català de Nanociència i Nanotecnologia (ICN2) and Co-Founder of INBRAIN Neuroelectronics . Together, they’ll explore how groundbreaking materials like graphene are shaping the future of neuroelectronic therapies and opening new frontiers in healthcare. 📍 Location: @Norrsken, Beach Lounge 📅 Date: November 6 🕑 Time: 2:10 pm – 2:40 pm Don’t miss this opportunity to gain insights into the latest advancements at the intersection of nanotechnology and healthcare innovation! #AsabysPartners #ImpactWeek #HealthcareInnovation #Nanotechnology #Graphene #Neuroelectronics

Asabys Partners

Thanks The Guardian and editor Robin McKie for following and reporting on our story The size of a postage stamp, the device is made of graphene, a material 200 times stronger than steel and only one atom thick. Graphene was invented 20 years ago by Manchester University scientists Andre Geim and Konstantin Novoselov, who later won the 2010 Nobel prize in physics for their research. Scientists have since been working to exploit the remarkable conductive properties of graphene in order to develop new electrical and magnetic sensors and other devices. However, the flexible brain chip – now being trialled at Salford Royal hospital – is being hailed as a medical first. “This is the first ever clinical trial to be performed anywhere in the world with a graphene-based medical device,” said one of the team’s leaders, Kostas Kostarelos , a professor of nanomedicine at Manchester. https://lnkd.in/dyayCRay

Ending this amazing week with winning the IGA2024 Graphene Product Innovation Award today! 🎉🎉🎉 Thank you to the International Graphene Association. “They have leveraged groundbreaking graphene technology to successfully conduct the world's first human trials for highly precise and minimally-invasive neuron detection and treatment solutions, driving innovation in brain-machine interfaces and neurological disorder therapies. Their remarkable achievements not only highlight the immense potential of graphene in the medical field but also offer unprecedented hope to neurological patients globally. Congratulations to Inbrain Neuroelectronics for winning the IGA 2024 Graphene Product Innovation Award for their newly developed graphene-based brain implant.” Thanks Stephan Roche for taking the prize on our behalf! More details about the event: http://www.grapchina.com/

HUGE UPDATE!🚨 INBRAIN Neuroelectronics has secured a $50 MILLION Series B financing round, led by imec.xpand . With this funding, they’ll accelerate the development and commercialisation of their BCI therapeutics through supporting ongoing clinical trials, team expansion and developing their AI-powered platform for the treatment of neurological-related diseases. They’re making absolute waves in the neurological space, read the full story here 👉 https://lnkd.in/eVwCvvzD

University of Manchester Innovation Factory

Our team in Business Insider España : https://lnkd.in/ewyffbY5

Thanks Longevity.Technology for covering our funding news! https://lnkd.in/e_vb_Zyf

msh id	COM:INBRAIN-NEUROELECTRONICS
symbol	-
name	Inbrain Neuroelectronics
homepage url	https://inbrain-neuroelectronics.com
country	ES
sector	Healthcare & Health Services
industry	Medical Devices
market	PRIVATE
employee count	-
crunchbase url	https://www.crunchbase.com/organization/inbrain-neuroelectronics
linkedin url	https://www.linkedin.com/company/inbrain-neuroelectronics/
founders	-

market cap	-
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-
growth ebitda ratio	-
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-
growth gross profit ratio	-

INBR

COM:INBRAIN-NEUROELECTRONICS

Inbrain Neuroelectronics

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	-
cost of revenue	-
depreciation and amortization	-
ebitda	-
ebitda ratio	-
eps	-
eps diluted	-
operating expenses	-
operating income	-
operating income ratio	-

accounts receivables	-
capital expenditure	-
cash at beginning of period	-
cash at end of period	-
inventory	-
working capital ttm	-

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-